Cargando…

Proton Pump Inhibitor Induced Depigmentation in Vitiligo

Detalles Bibliográficos
Autores principales:	Holla, Anantha Prasad, Kumar, Ravinder, Parsad, Davinder, Kanwar, AJ
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081486/ https://www.ncbi.nlm.nih.gov/pubmed/21572683 http://dx.doi.org/10.4103/0974-2077.79193

Ejemplares similares

Modified Procedure of Noncultured Epidermal Suspension Transplantation: Changes are the Core of Vitiligo Surgery
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Quality of life in patients with vitiligo
por: Parsad, Davinder, et al.
Publicado: (2003)

A New Era of Vitiligo Research and Treatment
por: Parsad, Davinder
Publicado: (2013)

Clinical and Molecular Aspects of Vitiligo Treatments
por: Bishnoi, Anuradha, et al.
Publicado: (2018)

Stability in Vitiligo: Is there a Perfect Way to Predict it?
por: Sahni, Kanika, et al.
Publicado: (2013)

Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
por: Agarwal, Priti, et al.
Publicado: (2014)

CCL22 to activate Treg migration and suppress depigmentation in vitiligo
por: Eby, Jonathan M., et al.
Publicado: (2015)

Psychosocial and quality-of-life factors associated with depigmentation therapy for vitiligo
por: Cadmus, Simi D., et al.
Publicado: (2023)

7(th) International Vitiligo and Pigment Cell Disorders Symposium, Istanbul, Turkey, November 21–23, 2014
por: Schwartz, Robert A, et al.
Publicado: (2015)

VITILIGO: A REVIEW OF SOME FACTS LESSER KNOWN ABOUT DEPIGMENTATION
por: Nordlund, James J
Publicado: (2011)

Depigmentation Therapy with Q-Switched Nd: YAG Laser in Universal Vitiligo
por: Majid, Imran, et al.
Publicado: (2013)

Tislelizumab Induced Vitiligo-Like Depigmentation in a Chinese Patient with Oesophageal Squamous Cell Carcinoma
por: Li, Ping, et al.
Publicado: (2022)

Vitiligo-Like Depigmentation following Treatment with Imiquimod 5% Cream for Condylomata Acuminata
por: Alatabani, Maram, et al.
Publicado: (2021)

Radiofrequency: The Next Step for Gingival Depigmentation
por: Pitak-Arnnop, Poramate, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream
por: Kim, Na Hee, et al.
Publicado: (2018)

Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine
por: Bakr, Farrah, et al.
Publicado: (2022)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Melanoma Inhibitory Activity (MIA) Is Able to Induce Vitiligo-Like Depigmentation in an in vivo Mouse Model by Direct Injection in the Tail
por: Bordignon, Matteo, et al.
Publicado: (2020)

Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study
por: Hermann, Nicola, et al.
Publicado: (2022)

PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin
por: Miao, Xiao, et al.
Publicado: (2018)

Nivolumab-associated vitiligo-like depigmentation in a patient with acute myeloid leukemia: A novel finding
por: Yin, Emily S., et al.
Publicado: (2017)

Equine vitiligo-like depigmentation in grey horses is related to genes involved in immune response and tumor metastasis
por: Druml, Thomas, et al.
Publicado: (2021)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Gold Ring Induced Depigmentation
por: Nayak, Sudhir UK, et al.
Publicado: (2013)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

The costly case of proton-pump inhibitors: a single-center experience
por: Suresh Kumar, Vishnu Charan, et al.
Publicado: (2020)

Depigmentation Following Diphenylcyclopropenone Immunotherapy Leading to Discontinuation of Treatment
por: Hanumanthu, Vinod, et al.
Publicado: (2022)

Proton-pump inhibitors should be strictly prescribed in clinic
por: Yang, Xuesong, et al.
Publicado: (2022)

Vitiligo-like depigmentation after pembrolizumab treatment in patients with non-small cell lung cancer: a case report
por: Yun, Sook Jung, et al.
Publicado: (2020)

Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients
por: Zirk-Sadowski, Jan, et al.
Publicado: (2017)

Deprescribing in older people: helpful tools and proton pump inhibitors
Publicado: (2020)

Exploration of Proton Pump Inhibitors Use During Pregnancy and Preeclampsia
por: Choi, Ahhyung, et al.
Publicado: (2021)

COVID-19 Mortality: The Culprit May Not Be Proton Pump Inhibitors
por: Duan, Zhihui, et al.
Publicado: (2022)

Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer
por: Raoul, Jean-Luc, et al.
Publicado: (2021)

Effect of proton pump inhibitor use on Helicobacter pylori positivity and atrial fibrillation
por: Atay, Kadri, et al.
Publicado: (2015)

Body Hair Transplantation in Vitiligo
por: Chouhan, Kavish, et al.
Publicado: (2013)

Lenalidomide Augments Differentiation of Cultured Hair Follicle Derived Melanocyte Stem Cells Into Functional Melanocytes
por: Kumari, Uma, et al.
Publicado: (2023)

A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8(+) T cell accumulation in the skin
por: Harris, John E., et al.
Publicado: (2012)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0s58lndfjg72ssv7ki1ooc529l